Navigation Links
Uninsured With Mental Illness and Addiction Disorders Not Covered by State Healthcare Initiatives
Date:7/17/2008

for mental illnesses in initiatives for the uninsured, but only 28% provide equal coverage for addiction disorders.
  • Basic parity is not enough. More states need to address problems with scope of benefits, co-payments, prior approvals, and shortages of behavioral health professionals.
  • Few states are including mental illness and addiction disorders in wellness and chronic disease management programs.

    • About the National Council

    The National Council for Community Behavioral Healthcare is a not-for-profit, 501(c)(3) association of 1,400 behavioral healthcare organizations. Member organizations provide treatment and rehabilitation services for mental illnesses and addictions disorders to nearly six million adults, children and families in communities across the country.

    Contacts
    National Council: Meena Dayak, 301-984-6200, ext. 228, MeenaD@thenationalcouncil.org

    # # #


    '/>"/>
    Source: PRWeb
    Copyright©2008 Vocus, Inc.
    All rights reserved  

    0

    GOOD

    Page: 1 2

    Related medicine news :

    1. 1,000th Uninsured Virginia Patient Secures Access to Quality Medical Care Through Virginia Cares Uninsured Program (VCUP)
    2. Poor and uninsured patients more likely to experience racial discrimination
    3. AMA Reinforces Commitment to Cover the Uninsured at Annual Meeting
    4. Campaign Aims to Cover 1,000 Uninsured Children in One Day
    5. The CoverMe Foundation Offers Free, Step-By-Step Assistance to Connect Uninsured with Free or Reduced-Cost Health Care
    6. AUDIO from Medialink and Pfizer: Free Programs for Uninsured Men and Women Who Need Help Paying for Medicine
    7. Cover The Uninsured Week and Project Healthy Living Save Lives
    8. Sacramento Man Finished 100-Mile-Run in 100 Degree Heat to Secure Health Care for Uninsured Children
    9. Graduates Forced to Join Millions of Uninsured Americans
    10. PA Governor Says Financial Analysis Shows Nothing Stands in Way of Senate Action to Help Pennsylvanias Uninsured
    11. Middle Class Uninsured Kids Health Risk Almost as High as Poor Childrens
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    Related Image:
    Uninsured With Mental Illness and Addiction Disorders Not Covered by State Healthcare Initiatives
    Uninsured With Mental Illness and Addiction Disorders Not Covered by State Healthcare Initiatives
    Breaking Medicine Technology:Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 2Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 3Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 4Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities 5Veran Medical Receives FDA Clearance to Market Electromagnetic Navigated Bronchoscopy Product: The SPiN Drive(TM) System 2AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa 2AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa 3FDA Announces Plans for LASIK Quality of Life Project 59587 1FDA Announces Plans for LASIK Quality of Life Project 59587 2FDA Announces Plans for LASIK Quality of Life Project 59587 3FDA Warns of Unapproved and Illegal H1N1 Drug Products Purchased Over the Internet 59582 1FDA Warns of Unapproved and Illegal H1N1 Drug Products Purchased Over the Internet 59582 2FDA Warns of Unapproved and Illegal H1N1 Drug Products Purchased Over the Internet 59582 3BioMed Realty Trust to Report 2009 Third Quarter Results 59577 1BioMed Realty Trust to Report 2009 Third Quarter Results 59577 2
    Other Medicine Technology:New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 2New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 3New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 4New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 5New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 6New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 7New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 8New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 9New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 10New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 11New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 12New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 13New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 14QRxPharma Releases Successful Phase 3 Study Results for 'Dual Opioid' Pain Therapy 2QRxPharma Releases Successful Phase 3 Study Results for 'Dual Opioid' Pain Therapy 3